| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |